Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Efficacy, Safety, and Tolerability Rollover Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy

ClinicalTrials.gov ID: NCT01540409

Public ClinicalTrials.gov record NCT01540409. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 2:29 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Open-Label, Multiple-Dose, Efficacy, Safety, and Tolerability Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy Who Participated in Study 4658-US-201

Study identification

NCT ID
NCT01540409
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Sarepta Therapeutics, Inc.
Industry
Enrollment
12 participants

Conditions and interventions

Interventions

  • AVI-4658 (Eteplirsen) Drug

Drug

Eligibility (public fields only)

Age range
7 Years to 13 Years
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 26, 2012
Primary completion
Apr 14, 2016
Completion
Aug 15, 2017
Last update posted
Mar 29, 2020

2012 – 2017

United States locations

U.S. sites
11
U.S. states
11
U.S. cities
11
Facility City State ZIP Site status
Miller Children's Hospital Long Beach California 90806
University of Florida Clinical Research Center Gainesville Florida 32610
Rush University Medical Center Chicago Illinois 60612
Massachusetts General Hospital Boston Massachusetts 02114
Washington University Medical School St Louis Missouri 63110
Summerwood Pediatrics/Infusacare Medical Services Liverpool New York 13088
Levine Children's Hospital Charlotte North Carolina 28203
Nationwide Children's Hospital Columbus Ohio 43205
Children's Hospital of Pittsburgh of UPMC Pittsburgh Pennsylvania 15224
Children's Specialty Group, Pediatric Neurology Norfolk Virginia 23510
Osceola Medical Center Osceola Wisconsin 54020

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01540409, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 29, 2020 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01540409 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →